StockData
ABVC BioPharma, Inc. logo

ABVC BioPharma, Inc. (ABVC) stock

ABVCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ECOC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 2/30
$0.94+0.03 (+3.30%)

Close on Nov 16, 2026Market cap $25.06MP/E –Yield –

ABVC BioPharma price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

ABVC BioPharma's price to sales ratio was 49.7× on Apr 30, 2025, against 65.1× a year earlier. Over the last 4 years it ranged from 4.5× to 334.9×, with a median of 80.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Apr 30, 202549.7×+35.0
2024Dec 31, 202414.7×+7.1
2023Dec 29, 20237.6×−145.7
2022Jan 31, 2022153.2×−54.6
2021Dec 31, 2021207.8×+8.1
2020Dec 31, 2020199.7×–

More ABVC BioPharma figures

See a number that looks wrong?